跳至主要内容
临床试验/CTRI/2020/07/026872
CTRI/2020/07/026872尚未招募2 期

Therapeutic Evaluation of Effects of Hijama Bil Shart in the Management of Zaghtuddam Qawi Ibtedai (Primary Hypertension) in comparison with Amlodipine.

CCRUM New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1-Patients with primary mild hypertension (ranging between systolic pressure 140 to 159 mmHg and /or diastolic pressure 90 to 99 mmHg).
  • 2-Age between 28 to 65 years
  • 3-Male/Female/Irrespective gender
  • 4-Chronicity of disease up to 10 year

排除标准

  • Physiological Status
  • 1-Patients below 28 and above 65 years of age.
  • 2-Pregnancy and lactation.
  • 3-Menstruation and postpartum hemorrhage.
  • Pathological Status
  • 4-Secondary Hypertension.
  • 5-Moderate and Severe Hypertension.
  • 6-Diabetes Mellitus.
  • 7-History of bleeding disorders.
  • 9-Bleeding piles.
  • 10-Chronic renal failure and liver failure.
  • 11-History of Myocardial infarction and Ischemic Heart Disease.
  • 12-Bronchial Asthma and COPD.
  • 13-HIV and/ or HbsAg positive.

研究者

发起方
CCRUM New Delhi

相似试验